Skip to main content
Premium Trial:

Request an Annual Quote

Hologic Wins $119M Contract From US Government to Expand COVID-19 Test Capacity

NEW YORK ─ Hologic said on Friday that it has been awarded a $119 million contract from the US government to expand its production capacity for COVID-19 molecular tests.

The contract was awarded by the Department of Defense Joint Rapid Acquisition Cell, the Department of the Air Force's Acquisition COVID-19 Task Force, and the US Department of Health and Human Services' Biomedical Advanced Research and Development Authority (BARDA), with BARDA providing the funding.

Marlborough, Massachusetts-based Hologic said the contract will support capital and labor investments to enable it to provide 13 million COVID-19 tests per month for the US market by January 2022.

The firm's Panther Fusion SARS-CoV-2 Assay and Aptima SARS-CoV-2 Assay received Emergency Use Authorization from the US Food and Drug Administration in March 2020 and May 2020, respectively.

The tests run on Hologic's fully automated Panther Fusion and Panther systems, which provide initial results in approximately three hours and process more than 1,000 tests in 24 hours, Hologic said. More than 2,000 of the systems have been installed in clinical diagnostic laboratories around the world, the firm added.

Hologic noted that BARDA is also separately supporting the development of its COVID-19 assays. In May, BARDA announced it awarded the company $13 million for the development of the Aptima SARS-CoV-2 assay, and in March it awarded Hologic $699,000 to develop the Fusion SARS-CoV-2 test.

The Scan

Quality Improvement Study Compares Molecular Tumor Boards, Central Consensus Recommendations

With 50 simulated cancer cases, researchers in JAMA Network Open compared molecular tumor board recommendations with central consensus plans at a dozen centers in Japan.

Lupus Heterogeneity Highlighted With Single-Cell Transcriptomes

Using single-cell RNA sequencing, researchers in Nature Communications tracked down immune and non-immune cell differences between discoid lupus erythematosus and systemic lupus erythematosus.

Rare Disease Clues Gleaned From Mobile Element Insertions in Exome Sequences

With an approach called MELT, researchers in the European Journal of Human Genetics uncovered mobile element insertions in exomes from 3,232 individuals with or without developmental or neurological abnormalities.

Team Tracks Down Potential Blood Plasma Markers Linked to Heart Failure in Atrial Fibrillation Patients

Researchers in BMC Genomics found 10 differentially expressed proteins or metabolites that marked atrial fibrillation with heart failure cases.